ABNOM
☆ AI Dermatology — Free Service
Dina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar.
Dina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar.
relevance score : -100.0%
ReferencesLaser Q‑switched Nd:YAG dipikanyaho sacara efektif ngubaran nevus Ota sareng kaayaan anu sami. Urang ngalaksanakeun hiji ulikan pikeun ningali kumaha hiji high‑fluence 1064 nm Q‑switched Nd:YAG laser digawé dina bintik Mongol di wewengkon mahkota, tanpa ngabalukarkeun kulit jadi lighten. Kami nalungtik 61 penderita bintik ieu, kalayan total 70 lesi. Satengah tina lesi dirawat ku laser, sedengkeun satengah deui teu dirawat pikeun dijadikeun kontrol. Kami ngévaluasi hasil ngagunakeun skala sareng alat anu disebut Mexameter® pikeun ngukur tingkat melanin. Pasén dipantau rata‑rata 14 bulan dina grup perlakuan jeung 18 bulan dina grup observasi. Dina ahir panalungtikan, urang manggihan béda signifikan dina skor skala jeung tingkat melanin antara grup anu dirawat jeung anu teu dirawat, kalayan grup laser nunjukkeun hasil anu leuwih hadé. Laser high‑fluence Q‑switched Nd:YAG, tanpa nyababkeun pencerahan kulit, kabuktian efektif jeung aman pikeun ngubaran bintik Mongol anu teu biasa ieu.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
Urang diajar efektivitas jeung kaamanan ngagunakeun perlakuan laser husus pikeun ABNOM, sarta nempo faktor naon anu bisa mangaruhan kumaha ogé gawéna. Kami ningali 110 pasien anu ngagaduhan ABNOM sareng ngalakukeun antara dua jeung salapan perlakuan laser. Kami mendakan yén pangobatan leuwih saé lamun dilakukeun sacara rutin, tapi henteu leuwih saé dina pasien anu geus lami ngalaman ABNOM. Éta ogé leuwih efektif pikeun pasien anu kulitna leuwih hampang (tipe III) jeung lesi anu leutik (kirang ti 10 cm²). Ayana melasma jeung ABNOM ngajadikeun pangobatan kirang efektif. Warna atawa ukuran lesi teu némbongkeun bédana signifikan. Sakitar 10 % pasien ngalaman bintik poék sanggeus perawatan. Hasil anu saé biasana katingali sanggeus sababaraha sesi perlakuan. Pasien anu leuwih kolot, kulitna leuwih poék, jeung bintikna leuwih poék leuwih kamungkinan meunang bintik poék sanggeus perawatan. Pikeun penderita ABNOM jeung melasma, leuwih hadé ngagunakeun laser kalayan énergi handap pikeun ngahindarkeun melasma jadi leuwih parah.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
○ Perlakuan
Agén pemutih jarang ngabantu. Béda jeung melasma, ABNOM bisa dironjatkeun ku perawatan laser sarta biasana teu balik deui sanggeus dihapus. Perawatan laser biasana dipigawé 10 nepi ka 20 kali pikeun ngubaran ABNOM.
#QS1064 laser